Neurodevelopment in Term Infants with Normal Birthweight following Postnatal Systemic Steroid Exposure

• Published in: Neuroepidemiology Vol. 58; no. 3; pp. 199 - 207
• Main Authors: Yi, Yoon Young, Ha, Eun Kyo, Shin, Jiwoon, Baek, Hey-Sung, Cha, Hye Ryeong, Kim, Ju Hee, Han, Man Yong
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland 31.01.2024
• Subjects: Original Paper; Neurodevelopmental screening test; Systemic steroid; Infancy; Children
• ISSN: 0251-5350; 1423-0208
• DOI: 10.1159/000536100

Abstract Introduction: Studies investigating the potential impact of systemic steroid exposure during early infancy on neurological development in full-term infants with normal birth weight are lacking. Methods: This population-based administrative cohort study used data of national health insurance and a health-screening program for infants and children and included full-term infants who were born in Korea between 2008 and 2012 with normal birth weight and did not have any specific perinatal or neurodevelopmental diseases. The prescription of systemic steroids within the first 3 months of age was mainly considered. The neurological development of children was assessed using the Korean Development Screening Test (K-DST) at 6 years of age. To balance the baseline characteristics of the control and exposed groups, stabilized inverse probability of treatment weighting with trimming was performed in the main cohort. Ordinal logistic regression was used to assess the association between systemic steroid exposure and unfavorable results in the K-DST. Results: The control and exposure groups had 246,168 and 5,083 children, respectively. The K-DST suggested unfavorable results in 8.1% and 8.6% children in the control and exposure groups, respectively (weighted odds ratio, 95% confidence interval, 1.03, 0.93–1.14). When each domain of the K-DST was considered separately, the risk of unfavorable results in the exposed group was not significantly different from that in the control group. Conclusions: No significant association was observed between exposure to systemic steroids during early infancy and neurodevelopmental impairment at 6 years of age.